167 related articles for article (PubMed ID: 32953243)
1. Comparative Analysis of Multiplex Platforms for Detecting Vitreous Biomarkers in Diabetic Retinopathy.
Lamy R; Farber-Katz S; Vives F; Ayanoglu G; Zhao T; Chen Y; Laotaweerungsawat S; Ma D; Phone A; Psaras C; Li NX; Sutradhar S; Carrington PE; Stewart JM
Transl Vis Sci Technol; 2020 Sep; 9(10):3. PubMed ID: 32953243
[TBL] [Abstract][Full Text] [Related]
2. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
Wang Y; Gao S; Zhu Y; Shen X
Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy.
Li J; Lu Q; Lu P
BMC Ophthalmol; 2018 Jun; 18(1):151. PubMed ID: 29940965
[TBL] [Abstract][Full Text] [Related]
4. Proximity Extension Assay (PEA) Platform to Detect Vitreous Biomarkers of Diabetic Retinopathy.
Lamy R; Ma'ayeh S; Chlamydas S; Stewart JM
Methods Mol Biol; 2023; 2678():135-145. PubMed ID: 37326709
[TBL] [Abstract][Full Text] [Related]
5. [New exploration of treatment target for proliferative diabetic retinopathy based on iTRAQ LC-MS/MS Proteomics].
Wen DJ; Ren XJ; Dong LJ; He Y; Li XR
Zhonghua Yan Ke Za Zhi; 2019 Oct; 55(10):769-776. PubMed ID: 31607066
[No Abstract] [Full Text] [Related]
6. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy.
Gao BB; Chen X; Timothy N; Aiello LP; Feener EP
J Proteome Res; 2008 Jun; 7(6):2516-25. PubMed ID: 18433156
[TBL] [Abstract][Full Text] [Related]
7. Correlation of Aqueous, Vitreous, and Plasma Cytokine Levels in Patients With Proliferative Diabetic Retinopathy.
Wu F; Phone A; Lamy R; Ma D; Laotaweerungsawat S; Chen Y; Zhao T; Ma W; Zhang F; Psaras C; Stewart JM
Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):26. PubMed ID: 32084272
[TBL] [Abstract][Full Text] [Related]
8. The Profile of Angiogenic Factors in Vitreous Humor of the Patients with Proliferative Diabetic Retinopathy.
Yu Y; Zhang J; Zhu R; Zhao R; Chen J; Jin J; Tian Y; Su SB
Curr Mol Med; 2017 Dec; 17(4):280-286. PubMed ID: 29110608
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of vitreous humor chemokines in type 2 diabetic patients with and without diabetic retinopathy.
Zeng Y; Cao D; Yu H; Hu Y; He M; Yang D; Zhuang X; Zhang L
Acta Diabetol; 2019 Jul; 56(7):797-805. PubMed ID: 30911832
[TBL] [Abstract][Full Text] [Related]
10. Safety and Feasibility of Quantitative Multiplexed Cytokine Analysis From Office-Based Vitreous Aspiration.
Ghodasra DH; Fante R; Gardner TW; Langue M; Niziol LM; Besirli C; Cohen SR; Dedania VS; Demirci H; Jain N; Jayasundera KT; Johnson MW; Kalyani PS; Rao RC; Zacks DN; Sundstrom JM
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3017-23. PubMed ID: 27273720
[TBL] [Abstract][Full Text] [Related]
11. Expression of angiopoietin-like protein 8 correlates with VEGF in patients with proliferative diabetic retinopathy.
Lu Q; Lu L; Chen W; Lu P
Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1515-1523. PubMed ID: 28456825
[TBL] [Abstract][Full Text] [Related]
12. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
Hernández C; Burgos R; Cantón A; García-Arumí J; Segura RM; Simó R
Diabetes Care; 2001 Mar; 24(3):516-21. PubMed ID: 11289478
[TBL] [Abstract][Full Text] [Related]
13. Identification of VEGF-independent cytokines in proliferative diabetic retinopathy vitreous.
Bromberg-White JL; Glazer L; Downer R; Furge K; Boguslawski E; Duesbery NS
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6472-80. PubMed ID: 24003089
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy.
Rezzola S; Corsini M; Chiodelli P; Cancarini A; Nawaz IM; Coltrini D; Mitola S; Ronca R; Belleri M; Lista L; Rusciano D; De Rosa M; Pavone V; Semeraro F; Presta M
Diabetologia; 2017 Apr; 60(4):719-728. PubMed ID: 28083635
[TBL] [Abstract][Full Text] [Related]
15. microRNA Expression Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients and Differences from Patients Treated with Anti-VEGF Therapy.
Friedrich J; Steel DHW; Schlingemann RO; Koss MJ; Hammes HP; Krenning G; Klaassen I
Transl Vis Sci Technol; 2020 May; 9(6):16. PubMed ID: 32821513
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Funatsu H; Yamashita H; Nakanishi Y; Hori S
Br J Ophthalmol; 2002 Mar; 86(3):311-5. PubMed ID: 11864890
[TBL] [Abstract][Full Text] [Related]
17. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y
Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618
[TBL] [Abstract][Full Text] [Related]
18. Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy.
Chernykh VV; Varvarinsky EV; Smirnov EV; Chernykh DV; Trunov AN
Indian J Ophthalmol; 2015 Jan; 63(1):33-6. PubMed ID: 25686060
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
20. ANGPTL-4 correlates with vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Lu Q; Zou W; Chen B; Zou C; Zhao M; Zheng Z
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1281-8. PubMed ID: 26483143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
